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Introduction
Dendritic cells (DCs) are regulators of the immune response 
whose antigen-processing activities are controlled in response 
to inflammatory stimuli (e.g., lipopolysaccharides [LPSs]) 
(Banchereau and Steinman, 1998). Among antigen-presenting 
cells, DCs are the most effi  cient at initiating antigen-specifi  c 
responses, inducing differentiation of naive T cells. Upon stim-
ulation, DCs begin a maturation process characterized by dra-
matic functional changes, such as cytokine production (e.g., 
IL-12) or up-regulation of antigen presentation capacity (Mellman 
and Steinman, 2001). TLR-4 signaling by LPS activates two 
major pathways resulting in DC maturation (Kaisho and Akira, 
2001). The fi  rst results in IKK, JNK, and p38 stimulation through 
the MyD88-IRAK-TRAF6 pathway. The second involves the 
Toll-IL-1 receptor domain-containing adaptor-inducing IFN-β 
(TRIF) and IRF3, which leads to type I interferon expression 
and costimulatory molecule up-regulation. Both pathways are 
required for optimal NF-κB activation. DC activation results 
therefore in the enhanced ability to stimulate and polarize T cells 
in vitro and in vivo.
A large proportion of newly synthesized proteins termed 
DRiPs are abnormal and degraded rapidly, thus contributing 
importantly to the MHC class I restricted endogenous antigenic 
peptide pool (Princiotta et al., 2003). Upon activation, DCs 
store ubiquitinated DRiPs in cytosolic bodies called dendritic 
cell aggresome-like induced structures (DALIS) (Lelouard et al., 
2002). Ubiquitinated DRiPs storage in DALIS delays their 
processing and could contribute to regulate MHC class I pre-
sentation (Herter et al., 2005; Pierre, 2005). DRiPs and DALIS 
formation are tightly linked to protein synthesis and quality 
control (Lelouard et al., 2004). Through this study we explore 
different aspects of mRNA translation regulation and its conse-
quences for DC function.
Protein synthesis regulation can be achieved through 
phosphorylation, inhibition, and proteolysis of key translation 
factors (Gingras et al., 1999). Extracellular stimuli such as growth 
factors activate translation through phosphoinositide 3-kinase 
(PI3K) and Ras signaling pathways. In contrast, viruses and 
cellular stresses inhibit translation through the phosphorylation 
and/or proteolytic cleavage of initiation factors such as eIF2α 
and eIF4GI (Holcik and Sonenberg, 2005). In addition to a gen-
eral decline in protein synthesis, these events allow the transla-
tion of specifi  c viral- or stress-related mRNAs. These mRNAs 
bear a complex structural element called internal ribosome 
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n response to inﬂ  ammatory stimulation, dendritic cells 
(DCs) have a remarkable pattern of differentiation 
(maturation) that exhibits speciﬁ  c mechanisms to con-
trol antigen processing and presentation. Here, we show 
that in response to lipopolysaccharides, protein synthesis 
is rapidly enhanced in DCs. This enhancement occurs 
via a PI3K-dependent signaling pathway and is key for 
DC activation. In addition, we show that later on, in a 
manner similar to viral or apoptotic stress, DC activation 
leads to the phosphorylation and proteolysis of important 
translation initiation factors, thus inhibiting cap-dependent 
translation. This inhibition correlates with major changes 
in the origin of the peptides presented by MHC class I 
and the ability of mature DCs to prevent cell death. Our ob-
servations have important implications in linking trans-
lation regulation with DC function and survival during the 
immune response.
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entry site (IRES) that can directly recruit ribosomes under stress 
conditions and bypass the need for a 
7mGpppN cap, which is 
 normally recognized by the translation initiation complex. Thus, 
cap-dependent and cap-independent translations are most often 
regulated in opposite ways, IRES-mediated translation being 
relatively ineffi  cient under physiological conditions.
We demonstrate here that LPS stimulation has a profound 
effect on the intensity and quality of translation in DCs both in 
vitro and in vivo. Translation control is tightly coordinated with 
the state of DC activation and can act independently of tran-
scription regulation. LPS-stimulated bone marrow–derived DCs 
fi  rst undergo a phase of rapid up-regulation of protein synthesis. 
We show that this translational activation mediated by the 
PI3K/AKT signal transduction pathway is necessary for cyto-
kine production, costimulatory molecules, and MHC class II 
surface up-regulation, as well as for DALIS formation in the 
fi  rst hours of LPS stimulation. At later stages of maturation 
eIF2α phosphorylation together with an increased production 
and degradation of eIF4GI and the eIF4GI-like factor DAP5, 
are correlated with the inhibition of cap-dependent translation 
and an increased resistance to apoptosis of mature DCs. Inhibition 
of cap-dependent translation also has an impact on MHC class I 
restricted antigen presentation, which at late time of DC matura-
tion loses its dependence on protein neo-synthesis. Thus, trans-
lation regulation in response to LPS is required for proper DC 
function and survival.
Results
Protein translation is regulated during 
DC maturation
Protein translation was monitored by [
35S]methionine/cysteine 
metabolic labeling in LPS-stimulated mouse bone marrow–
derived DCs. Two events were observed (Fig. 1 A). First, an 
important increase in protein synthesis peaking at 4 h was seen 
rapidly upon stimulation. From this time point on, methionine/
cysteine incorporation continuously decreased, reaching a lower 
level than in immature DCs (iDCs) after 16 h of maturation. 
To confi  rm this observation, a luciferase reporter mRNA was 
introduced in maturing DCs (mDCs) by transfection (Fig. 1 B). 
As in the pulse chase experiment, translation of luciferase, very 
active at 5 h of LPS activation, was progressively inhibited with 
maturation time. 
7mGpppG-capped mRNA transfection effi  ciency 
was determined by quantitative PCR and found equivalent at the 
different times of activation. A replacement of 
7mGpppG-cap 
by the cap analogue ApppG further demonstrated that mRNA 
capping is required to allow translation during the fi  rst hours 
of maturation. Thus, an enhancement of cap-mediated trans-
lation is observed at the initiation of maturation, immediately 
followed by a marked reduction, and this in a manner indepen-
dent of the mRNA levels present. These results were confi  rmed 
by monitoring protein synthesis in freshly explanted splenic 
CD11c
+ DCs from mice injected with LPS (Fig. 1 C). Auto-
radiography and corresponding phosphoimager quantifi  cation 
demonstrated the strong down-regulation of protein synthesis 
(threefold) in splenic dendritic cells isolated as soon as 3 h after 
LPS injection (6 h of total exposure including 3 h of manipulation). 
[
35S]methionine/cysteine incorporation levels were inversely 
correlated with phenotypical maturation of DCs as monitored by 
CD86 surface staining (Fig. 1 C). This inhibition was maintained 
for at least 16 h of LPS treatment, thus confi  rming that maturing 
DCs down-regulate heavily their protein synthesis in vivo.
Protein translational increase at the 
onset of maturation is mediated by a PI3K 
signaling pathway
PI3K, AKT, and the mammalian target of rapamycin (mTOR) 
are major components of the transduction pathway controlling 
mRNA translation (von Manteuffel et al., 1997; Raught et al., 
2000; Aoki et al., 2001; Ruggero and Sonenberg, 2005). Activa-
tion of this pathway leads to the phosphorylation of the S6 ribo-
somal protein by the cognate 70-kD S6 kinase (S6K1), which 
correlates well with the enhanced protein synthesis capacity of 
stimulated cells (Fingar et al., 2004). AKT phosphorylation was 
increased 15–30 min after LPS stimulation, followed by massive 
phosphorylation of S6, thus matching the rapid increase in protein 
synthesis (Fig. 2 A). Moreover, inhibition of the PI3K-dependent 
pathway with LY294002 (LY) inhibited effi  ciently AKT and 
S6 phosphorylation, thus confi  rming the importance of PI3K in 
initiating this signaling cascade in DCs. Wortmannin (another 
PI3K inhibitor) also inhibited S6 phosphory lation, although less 
effi  ciently than LY (Fig. 2 B). Inhibition of mTOR with rapa-
mycin markedly reduced S6 phosphorylation, strongly suggest-
ing that this kinase lying downstream of AKT and upstream of 
S6K1 is an important part of the signaling pathway leading to 
S6 phosphorylation upon LPS detection (Fig. 2 B). The impli-
cation of this pathway in controlling translation activation was 
further demonstrated by the limited [
35S]methionine/cysteine in-
corporation observed in metabolically pulsed maturing DCs 
treated with LY, while control cells displayed the expected up-
regulation of protein synthesis in response to LPS (Fig. 2 C).
Signal transduction upon TLR4 engagement by LPS is 
dependent on the two adaptors MyD88 and TRIF (Kaisho and 
Akira, 2001); although both adaptors are required for proper DC 
activation, their potential interaction and role in PI3K recruit-
ment is unclear (Arbibe et al., 2000). Thus, we evaluated the 
individual contribution of these molecules to translation acti-
vation in response to LPS using DCs derived from MyD88 (−/−) 
or TRIF (−/−) defi  cient mice. As expected, TRIF
−/− DCs and 
to a lesser level MyD88
−/− DCs were impaired in their LPS-
triggered maturation process (Fig. S1, available at http://www
.jcb.org/cgi/content/full/jcb.200707166/DC1). In both trans-
genic strains, S6 phosphorylation levels after LPS activation 
were considerably decreased compared with wild-type control 
(Fig. 2 D). In MyD88
−/− DCs, despite its reduced intensity, S6 
phosphorylation peaked after 90 min of activation like in wild-
type DCs (Fig. 2 D). In contrast, the peak of phosphorylation 
occurred earlier (30 min) in TRIF
−/− DCs. Because S6 phos-
phorylation displayed an exacerbated sensitivity to LY treatment, 
we could perform a sharper analysis of the adaptor contribution 
by immunoblotting LY-treated DC extracts. The lower intensity 
and the peaks of activity in absence of MyD88 (90 min) and 
TRIF (30 min) were conserved under these conditions (Fig. 2 D, 
bottom), thus suggesting that the two adaptors synergize to allow TRANSLATION REGULATION IN DCS • LELOUARD ET AL. 1429
the full phosphorylation of S6 upon LPS stimulation, but with 
some difference in their activation kinetics. MyD88 seems to 
initiate the response early after LPS detection (30 min peak in 
TRIF
−/− DCs), whereas TRIF seems to be involved at later times 
(90 min peak in MYD88
−/−) and thus complement MyD88 ac-
tivity to increase and sustain the signaling response for longer pe-
riod of activation. TLR4 signaling requires, therefore, both MyD88 
and TRIF adaptors for the full activation of PI3K leading to 
S6 phosphorylation and a strong up-regulation of translation.
Up-regulation of maturation markers 
and DALIS formation are linked to PI3K 
signaling and translation activation
DC activation is phenotypically characterized by the surface 
up-regulation of MHC and costimulatory molecules, which are 
required for effi  cient antigen presentation and T cell activation. 
MHC class II molecule redistribution from the lysosomes of 
iDC to the cell surface of mDC is a key event in this process 
(Pierre et al., 1997). However, the respective contribution of 
Figure 1.  Protein synthesis is regulated during DC maturation. (A) At the indicated time of LPS-induced maturation, DCs were pulsed for 10 min with 
35S-labeled Pro-Mix. Soluble fractions were prepared and analyzed by Coomassie blue staining (top) and autoradiography (bottom) after SDS-PAGE. (B) A ﬁ  reﬂ  y 
luciferase reporter mRNA was transfected in DCs. Left: luciferase activity was measured 4 h after transfection at the indicated time of maturation (absolute 
values of one representative experiment). Bottom right: comparative levels of translation of luciferase mRNAs modiﬁ  ed or not with an unmethylated 
cap-analogue in transfected 6 h and 20 h LPS-treated DCs. Error bars indicate the SD of three independent experiments. Due to variations of absolute values 
in the different experiments, the time point 6 h of 7mGpppG was deﬁ  ned as 100%. Transfection efﬁ  ciency was determined by quantitative PCR (top right, 
absolute values). (C) Spleen DCs, isolated from mice treated with PBS as control or 10 μg LPS i.p. for different times as indicated, were metabolically 
labeled. After SDS-PAGE, soluble fractions were stained with Coomassie blue (top) and 
35S incorporation was visualized by phosphoimaging (bottom) and 
quantiﬁ  ed (PSL = photostimulated luminescence). The maturation status of the DCs is shown by FACS analysis of CD86 (bottom).JCB • VOLUME 179 • NUMBER 7 • 2007  1430
preexisting and of newly synthesized molecules to this surface 
appearance is still debated. As translation is rapidly enhanced 
in response to LPS, we investigated the importance of PI3K 
  signaling and protein synthesis in surface appearance of classi-
cal maturation markers such as CD86, MHC class II, and the 
production of IL-12, a key cytokine for DC function and T cell 
differentiation. LY treatment abrogated the surface appearance 
of the different markers and the production of IL-12, as illus-
trated by FACS staining of CD11c
+ DCs activated with LPS (Fig. 
3 A). Thus, PI3K activity is absolutely required for functional 
LPS activation of DCs. Based on our observation that LY has a po-
tent inhibitory effect on protein synthesis in DCs, we next tested 
whether direct inhibition of protein synthesis with the transla-
tion inhibitor cycloheximide (CHX) could also negatively impact 
on DC maturation. Upon CHX addition, CD86 and MHC class II 
surface up-regulation as well as IL-12 production were fully 
inhibited after 3 h of treatment (Fig. 3 A). This further demon-
strates that protein neo-synthesis is required to achieve proper 
DC activation.
One of the hallmarks of DC activation is the formation of 
DALIS. They are transient, forming as soon as 3 h after DC 
activation, peaking at 8–12 h and disappearing 24–36 h later 
(Lelouard et al., 2002). DALIS formation and maintenance require 
continuous protein synthesis and seem to be linked to MHC 
class I restricted antigen processing (Herter et al., 2005). The strik-
ing correlation of DALIS appearance and disappearance with 
the translation variations observed in mDCs led us to investi-
gate the importance of protein synthesis regulation and PI3K 
signaling for their formation. DALIS were stained by the anti-
polyubiquitinated proteins monoclonal antibody FK2 and de-
tected by immunofl  uorescence confocal microscopy after LPS 
or poly I:C activation (Fig. 3 B, top). PI3K inhibition with LY 
completely blocked DALIS formation, independently of the mode 
of DC activation (Fig. 3 B, bottom). DALIS formation is therefore 
linked to PI3K signaling, probably through its translational up-
regulation effect.
Translation inhibition correlates with eIF2𝗂 
phosphorylation
Having demonstrated PI3K involvement in increasing trans-
lation in response to LPS, we next investigated by which molec-
ular mechanism(s) translation down-regulation could be achieved 
and its consequences during late phase of DC maturation. 
Cap-mediated translation inhibition can be achieved through 
the regulation of translation initiation by phosphorylation or 
proteolysis of key translation factors (Gingras et al., 1999). 
Cell defense pathways take advantage of four different kinases 
(e.g., PKR) to regulate protein synthesis in response to different 
environmental stresses by phosphorylating the α subunit of the 
translation initiation factor 2 (eIF2-α) (Anderson and Kedersha, 
2002; Gebauer and Hentze, 2004). Phosphorylated eIF2-α acts 
as a dominant-negative molecule and blocks the initiation of 
Figure 2.  The PI3K/AKT signal transduction 
pathway is involved in S6 phosphorylation and 
translational increase during DC activation. (A) 
Immunoblot of S6 (top) and AKT (bottom) phos-
phorylation at the onset of DC maturation and its 
inhibition by LY 294002 (LY). (B) DCs were pre-
treated with wortmannin, LY, or rapamycin prior 
stimulation and immunoblotted for phospho-S6 (P-S6). 
(C) Translation was monitored in DCs by 
35S-labeled 
Pro-Mix during the ﬁ  rst 2 h of LPS activation with 
or without LY treatment. (D) Immunoblot of P-S6 in 
DCs derived from C57BL6 (WT), MyD88
−/−, and 
TRIF
−/− mice and stimulated with LPS for the indi-
cated times, with (bottom) or without (top) pretreat-
ment with LY.TRANSLATION REGULATION IN DCS • LELOUARD ET AL. 1431
cap-dependent protein synthesis in stressed cells by inhibiting 
Met-tRNA recruitment.
We monitored eIF2α phosphorylation levels by immuno-
blot in maturing DCs (Fig. 4 A). eIF2α phosphorylation increased 
between 4 and 8 h of DC maturation, suggesting that a stress-
like response is induced by LPS. However, eIF2α phosphoryl-
ation in mDCs appeared limited when compared with control 
samples treated with arsenite (Fig. 4 A) in which translation was 
fully abrogated. Stress- or arsenite-induced eIF2α phosphoryl-
ation promotes the formation of stress granules (SGs), which serve 
as mRNA and preinitiation complex deposits until stress dimin-
ishes and protein synthesis can resume (Anderson and Kedersha, 
2002). Thus, SG formation is a relatively good indicator of the 
eIF2α phosphorylation and associated translation inhibition levels. 
Immunofl  uorescence confocal microscopy was used to visualize 
SGs using a fl  uorescent oligo-dT probe in 16-h maturing DCs 
(Fig. 4 B). In absence of arsenite treatment, SGs were never 
observed during DC maturation, further supporting that the 
increase in eIF2α phosphorylation in maturing DCs is truly modest. 
Thus, in response to LPS, limited phosphorylation of eIF2α 
may modulate mRNA translation quantity and quality (Morley 
et al., 2005), although it is unlikely solely responsible for the 
dramatic translation inhibition observed during DC maturation.
Alteration of eIF4GI during DC maturation
Alternatively, cap-dependent translation can also be inhibited 
by the cleavage of the scaffold translation initiation factor 
eIF4GI (Prevot et al., 2003; Holcik and Sonenberg, 2005; 
Spriggs et al., 2005) (Fig. 5 A). Proteolytic cleavage of eIF4GI 
by viral proteases or caspase-3 occurs during picornavirus and 
retrovirus infection as well as during cellular stress (Holcik and 
Sonnenberg, 2005). Proteolytic fragments of eIF4GI have been 
shown to compete with the recruitment of the complete cap-
binding protein complex eIF4F by the mRNAs, thereby limiting 
cap-dependent translation and favoring the internal ribosome 
entry sites (IRES)–mediated translation of a small number of 
specifi  c mRNAs (Bushell et al., 2000). Thus, we investigated 
by immunoblotting the fate of the scaffold translation initiation 
factor eIF4GI using an antibody recognizing a C-terminal epitope 
(α-C-FAG) (Cowan and Morley, 2004). Surprisingly, between 
8 and 14 h of LPS activation, a time at which cap-dependent 
translation is down-regulated, eIF4GI levels increased sturdily 
Figure 3.  Importance of protein translational increase 
for DALIS formation and DC immunological functions. 
(A) Impaired MHC class II and CD86 surface expression 
up-regulation and cytokine production in maturing DCs 
upon treatment with LY or CHX. FACS staining of IL-12 
synthesis and surface expression of MHC class II and 
CD86 in iDCs (black line) and mDCs (4 h light gray) are 
shown for different times of treatment with LY and CHX. 
(B) After 8 h of LPS (left) or poly I:C (right) stimulation 
in the absence or in the presence of the PI3K inhibitor 
LY294002, mice bone marrow–derived DCs were stained 
for ubiquitinated proteins (FK2) and visualized by confocal 
microscopy. Bar, 10 μm.JCB • VOLUME 179 • NUMBER 7 • 2007  1432
(Fig. 5 B). In contrast, the levels of the closely related homo-
logue eIF4GII and of eIF4A remained stable. The specific 
up-regulation of eIF4GI does probably not refl  ect a slower deg-
radation rate because several smaller fragments weakly present 
in iDCs also increased after 8 h of LPS treatment. Interestingly, 
eIF4GI translation is enhanced in a context of general cap-
dependent translation inhibition.
eIF4GI mRNA contains an IRES sequence, which favors 
eIF4GI neosynthesis in response to the accumulation of several 
of its own specifi  c proteolytic fragments (Byrd et al., 2005). 
Thus eIF4GI proteolysis was further investigated using anti-
bodies detecting epitopes spread along the entire length of the 
220-kD molecule (Fig. 5 A). They confi  rmed that levels of 
intact eIF4GI were increased, but also that the cleavage of 
the translation factor was strongly enhanced during DC matura-
tion (Fig. S2 A, available at http://www.jcb.org/cgi/content/full/
jcb.200707166/DC1). The higher molecular weight fragments 
migrating around 160 kD were recognized by all antibodies, 
and are therefore the result of a C-terminal cleavage that occurs 
downstream of the previously identifi  ed caspase-3 cleavage sites 
(Bushell et al., 2000). Based on the degradation patterns ob-
served by immunoblot, it was possible to identify three major 
areas of cleavage along eIF4GI (Fig. 5 C).
The fi  rst cleavage site is positioned after the PABP-binding 
site and when cleaved, separates the N terminus of eIF4GI (e.g., 
NFc4) recognized by antibodies such as α-Nt and α-PABPd 
from the rest of the molecule. The second region is located after 
the eIF4E-binding site, thus allowing the production of frag-
ments only recognized by α-P7 and α-P8 and containing the cap-
binding protein eIF4E interaction domain (e.g., MF4 and MF5). 
The last cleavage domain was mapped in the vicinity, but dis-
tinct of the last known caspase-3 cleavage site, and produces 
fragments recognized by α-P9, α-phospho-S1149, and α-C-FAG. 
The smaller eIF4GI fragments (e.g., MF4 and MF5), although 
containing the eIF4E binding site, were found to have a low 
affi  nity for eIF4E because they were not retained effi  ciently on 
a 
7mG-cap affi  nity column (Fig. S2 B). Conversely, higher mo-
lecular weight eIF4GI fragments (>100 kD), possessing several 
other binding domains, were effi  ciently retained on the column 
and could therefore compete in the cell with intact eIF4GI for 
the recruitment of the cap-binding protein eIF4E and associated 
mRNAs. Thus, these fragments are likely to participate to the 
down-regulation of cap-dependent translation occurring during 
DC activation.
Identiﬁ  cation of the proteolytic activity 
responsible for eIF4GI cleavage
In addition to caspase-3 and viral proteases known to degrade 
eIF4GI, the caspase-like activity of the proteasome has been 
shown in vitro to cleave eIF4GI in multiple fragments (Baugh 
and Pilipenko, 2004). To identify the protease(s) responsible for 
eIF4GI fragmentation, we used a panel of specifi  c proteasome 
and caspase inhibitors and performed an immunoblot on mDCs 
(Fig. 5 D). The lack of inhibitory effect observed in the presence 
of the caspase-3 inhibitor DEVD-FMK confi  rmed that this cas-
pase is not involved in eIF4GI cleavage in mDCs. Although none 
of the other specifi  c caspase inhibitors tested had any inhi-
bitory activity, the pan-caspase inhibitor Z-VAD-FMK pre-
vented the accumulation of eIF4GI fragments. The same effect 
was observed with the reversible proteasome inhibitor MG132. 
Figure 4.  eIF2𝗂 phosphorylation increases during DC 
maturation without inducing SG formation. (A) eIF2α levels 
remained constant during DC maturation (top) while its 
phosphorylation increased (bottom left) to a lesser extent 
than in mDCs treated with 500 μM arsenite (bottom right), 
as monitored by immunoblot. (B) mDCs were treated (bottom) 
or not (top) with arsenite before being stained for ubiq-
uitinated proteins (FK2; green), polyA+ mRNA (oligo-dT 
probe; red), and nuclei (TO-PRO-3; blue). SGs (red; arrows) 
induced upon arsenite treatment are not enriched in ubiqui-
tinated proteins (green), while DALIS (green; arrowheads) 
formed upon LPS treatment are not enriched in mRNA (red). 
Because SGs induced by arsenite did not contain ubiqui-
tinated proteins and conversely DALIS were not enriched in 
poly-adenylated mRNAs, these are distinct structures. Trans-
lation inhibition is responsible for the disappearance of 
DALIS in the arsenite-treated cells. Bar, 10 μm.TRANSLATION REGULATION IN DCS • LELOUARD ET AL. 1433
Thus, the caspase-like activity of proteasome is likely to medi-
ate at least partially the degradation of eIF4GI and play an active 
role in inhibiting translation in mature DCs.
Consequences of eIF4GI cleavage: 
IRES-mediated translation activation
In addition of being partly responsible for cap-mediated transla-
tion inhibition in mature DCs, we wondered if eIF4GI cleavage 
could have other functional consequences in DCs. Indeed, the 
major 50- to 65-kD fragments of eIF4GI (MF1 and MF2) are 
predicted to contain the fi  rst RNA-helicase eIF4A and the ribo-
some adaptor eIF3 binding domains, and are therefore equiva-
lent to the eIF4GI fragments generated by different retroviral 
proteases (Alvarez et al., 2003). These fragments, as well as 
those generated by apoptosis or cellular stress induction, are 
known to act as IRES-transacting factors (ITAFs) and are cen-
tral in switching from m
7G cap-dependent to IRES-mediated 
translation during viral infection or cellular stress (Holcik and 
Sonenberg, 2005; Spriggs et al., 2005). In addition to viral mRNAs, 
they have been shown to induce protein synthesis from the 
Figure 5.  Up-regulation and cleavage of eIF4GI during DC maturation. (A) Scheme of the murine eIF4GI largest isoform. Binding sites for PABP and the 
different translation initiation factors are boxed. The caspase-3 cleavage sites are indicated with arrowheads. Epitopes recognized by the different antibodies 
used throughout this study are organized according to their position in eIF4GI. (B) Conversely to eIF4GII (middle) and eIF4A (bottom), eIF4GI and associ-
ated fragments (top) are strongly increased after 8 h of maturation as monitored by immunoblot performed with α-C-FAG antibody. (C) Model of eIF4GI 
cleavage in mDCs. Extracts of mDCs were separated by SDS-PAGE and immunoblotted with different anti-eIF4GI antibodies. Fragment patterns were com-
pared as follows: bands recognized by only one antibody were eliminated; other bands were analyzed according to antibody reactivity (illustrated by 
  asterisks on the right of the immunoblot), molecular weight and comparison to the previously described cleavage products generated by caspase-3, 
proteasome, picornaviral, and HIV virus proteases. Three major proteolytic sensitive areas (gray boxes) and their putative products were deduced from 
antibody reactivity and molecular weights. NFc stands for N-terminal fragment cluster because several clustered bands are always displayed due to the ex-
istence of the multiple isoforms of eIF4GI. MF stands for middle fragment and CF for C-terminal fragment. (D) Alteration of eIF4GI during DC maturation 
is prevented by proteasome and pan-caspase inhibitors. Effects of protease inhibitors on eIF4GI fate in DCs were analyzed by immunoblot using the anti-
C-FAG antibody. Conversely to MG132 and Z-VAD-FMK, speciﬁ  c caspase inhibitors (YVAD, DEVD, IETD, LEHD, WEHD) had no effect on accumulation of 
eIF4GI fragments.JCB • VOLUME 179 • NUMBER 7 • 2007  1434
cellular mRNAs of the pro-apoptotic factor APAF1 and of the 
eIF4GI family member DAP5 (Fig. 6 A) (Nevins et al., 2003). 
We thus investigated whether APAF1 and DAP5 expression levels 
were modifi  ed during DC maturation by immunoblot (Fig. 6 B). 
APAF1 expression showed no signifi  cant variations upon DC 
maturation, whereas DAP5 expression was increased from 8 h 
of LPS activation. To examine whether the up-regulation of 
DAP5 could be due to transcriptional activation, quantitative 
PCR was performed (Fig. 6 C). DAP5 and APAF1 mRNAs were 
not induced more than twofold, DAP5 mRNA returning to basal 
levels after 8 h. Thus, mRNA transcription is not linearly corre-
lated with the level of protein accumulation.
DAP5 is crucial for the regulation of cell survival after 
apoptotic stress. During apoptosis, DAP5 is activated by a cleav-
age generating an 86-kD fragment (p86), resembling those of 
eIF4GI containing both eIF3 and eIF4A domains (Fig. 5 A and 
Fig. 6 A) and also able to stimulate IRES-mediated translation 
(Holcik and Sonenberg, 2005). The intact form of DAP5 was 
resolved by immunoblot of the mDC extracts as a doublet (p97 
and p95; Henis-Korenblit et al., 2000). Interestingly and in 
contrast to fi  broblasts, which express constitutively both forms 
(Fig. S3 A, available at http://www.jcb.org/cgi/content/full/
jcb.200707166/DC1), iDCs displayed solely the p95 isoform, 
the DAP5/p97 isoform being induced only after 8 h of LPS 
activation (Fig. 6 B). Interestingly, although p86 was only weakly 
detected throughout the maturation process, a previously uncharac-
terized DAP5 proteolytic N-terminal fragment of 45 kD (p45) 
and a potential complementary C-terminal fragment of 55 kD 
(p55) were strongly increased during maturation (Fig. 6 D).
Loss of eIF4GI and DAP5 up-regulation 
upon inhibition of their degradation
In addition of inhibiting cap-mediated translation, the proteo-
lytic cleavage of eIF4GI and/or DAP5 during maturation is 
likely to control their own expression at the translational level. 
Thus, conversely to a classical situation in which inhibiting the 
degradation of a given protein increases its total level, inter-
fering with eIF4GI cleavage should prevent the maturation-
induced up-regulation of eIF4GI and DAP5. In agreement 
with this hypothesis, when mDCs were treated with MG132, 
levels of eIF4GI and DAP5 were drastically reduced in a dose-
dependent manner (Fig. 7 A). In contrast to MG132, LHVS, a 
general inhibitor of cysteine proteases, had no effect on the 
translation factors levels. Importantly, protein synthesis inhibi-
tion with CHX also reduced eIF4GI and DAP5 levels, thus 
confi  rming the importance of active translation to maintain steady-
state levels of these molecules. To avoid potential indirect effect 
of MG132, the same experiment was conducted using Z-VAD-
FMK to inhibit eIF4GI cleavage. A similar loss of eIF4GI and 
DAP5 was observed (Fig. 7 B). Thus, a strong link between proteo-
lytic cleavage and increased production of the two translation 
factors exist in mDCs. Collectively, our results suggest that DC 
maturation promotes cleavage of eIF4GI and DAP5 into their 
potential ITAF fragments, thus boosting their own synthesis by 
favoring IRES-driven mRNA translation, in a global context of 
cap-mediated translation repression. Illustrating this conclusion 
and conversely to what occurred in mDCs, levels of eIF4GI and 
Figure 6.  DAP5 translational up-regulation and cleavage in mDCs. (A) 
Scheme of the murine DAP5. Binding sites for the different translation initia-
tion factors are boxed. (B) Immunoblots of maturing DCs for APAF1 (top) 
and DAP5 (bottom). Conversely to APAF1, DAP5 p95/p97 is increased 
during LPS activation. (C) Transcriptional regulation of DAP5 and APAF1. 
mRNAs were isolated at different stages of DC maturation and quantitative 
PCR was performed. The mRNA expression levels are indicated as fold 
regulation normalized to iDCs (0 h). Error bars indicate the SD of three 
  independent duplicated experiments. (D) Alteration of DAP5 during DC 
maturation. In addition to DAP5/p97, a 45-kD fragment (p45) detected 
by immunoblot with the α-DAP5 Nt antibody (top) is increased during DC 
maturation. A complementary fragment of 55 kD (p55) is also detected with 
the α-DAP5 Ct antibody (bottom).TRANSLATION REGULATION IN DCS • LELOUARD ET AL. 1435
DAP5 increased upon MG132 or Z-VAD-FMK treatment in iDCs 
(Fig. 7 C). eIF4GI cleavage is therefore only functionally impor-
tant in mature DCs.
Translation regulation correlates with 
mDC survival
In addition to their infl  uence on translation quality, eIF4GI and 
DAP5 fragments have been shown to be involved in cell death 
regulation by infl  uencing the translation of pro- or anti-apoptotic 
factors in response to environmental cues (Holcik and Sonenberg, 
2005). Lifespan of DCs can infl  uence the duration of DC inter-
action with lymphocytes, thereby affecting the outcome of lym-
phocyte activation and immune responses. DCs have a relatively 
rapid turnover in vivo (Jung et al., 2002), and several lines of 
evidence indicate that apoptosis can regulate DC functions 
(Hou and Van Parijs, 2004). Induction of cell death in DCs has 
been shown to limit the priming of antigen-specifi  c cytotoxic 
T cells, and apoptosis prevention potentially regulates the scope 
of immune responses and immune tolerance. We therefore tested 
if translation factor degradation could infl  uence mDC survival.
CD11c
+ DC resistance to cell death was quantifi  ed by moni-
toring annexin V surface staining after treatment with MG132 
or the pro-apoptotic drugs etoposide and staurosporine (Fig. 8 A). 
Although little LPS-induced death was observed, staurosporine 
treatment induced a strong annexin V labeling in 25% of the 
iDCs, whereas etoposide had a lesser effect. In contrast to iDCs, 
mDCs were not affected by the pro-apoptotic drugs, thus sug-
gesting that maturation enhances their resistance to induced 
cell death. The contribution of eIF4GI and DAP5 proteolytic 
cleavage to this enhanced survival capacity of mDCs was evalu-
ated using Z-VAD-FMK and MG132 at different doses (Fig. 8 A). 
Although MG132 treatment induced only a modest increase of 
cell death in iDCs, mDCs were extremely sensitive to the drug 
treatment. Most strikingly Z-VAD-FMK had no effect on iDCs 
even at higher doses (80 μM), while it effi  ciently promoted cell 
death in mDCs after a dose-dependent response in good corre-
lation with the prevention of eIF4GI and DAP5 cleavage. Collec-
tively, these results suggest that one of the functions of eIF4GI 
and DAP5 cleavage and translation inhibition in maturing DCs 
is to promote their survival, which otherwise might be affected 
by LPS stimulation.
Origin of MHC class I ligands changes from 
newly synthesized to preexisting antigens 
during DC maturation
MHC class I restricted peptides are derived from rapidly degraded 
proteins such as DRiPs, and peptide generation is strongly 
dependent on protein synthesis (Princiotta et al., 2003; Qian et al., 
2006a). The two phases of translation that we observed are thus 
likely to interfere directly with MHC class I presentation and 
consequently DC function. We therefore evaluated globally the 
generation of MHC class I/peptide complexes during DC matu-
ration using acid stripping experiments followed by MHC class I/
peptide recovery detected with the HB-176 mAb, which rec-
ognizes conformed H-2k
b molecules independently of the nature 
of bound peptides (Qian et al., 2006b). We could confi  rm that 
proteasome activity is required for peptide-H-2k
b recovery after 
acid stripping of the cells because the proteasome inhibitor 
MG132 abrogated the surface appearance of newly loaded MHC 
class I in maturing DCs (Fig. 8 B). Unexpectedly, we also ob-
served that DCs during the reduced translation phase (16 h of 
LPS) had the same rate of MHC class I/peptide recovery than 
DCs during the enhanced translation phase (4 h of LPS). To further 
evaluate the direct contribution of protein synthesis to MHC 
Figure 7.  Up-regulation of eIF4GI and DAP5 in mDCs is dependent on their own proteolytic cleavage. Immunoblot detection of eIF4GI and DAP5 in 16 h 
LPS-activated DCs exposed to pharmacological agents. (A) Conversely to the cysteine protease inhibitor LHVS, the proteasome inhibitor MG132 induced 
a dose-dependent loss of eIF4GI and DAP5 in mDCs, in a similar fashion to translation inhibition (CHX). (B) Inhibition of caspase-like activities in mDCs 
with Z-VAD-FMK had a dose-dependent effect comparable to that of MG132 or CHX on eIF4GI and DAP5 levels. (C) In iDCs, MG132 and Z-VAD-FMK 
treatments favored the accumulation of intact eIF4GI, whereas in mDCs the two drugs promoted its loss, as detected with the anti-C-FAG antibody. Actin 
immunoblots are shown for equal loading control.JCB • VOLUME 179 • NUMBER 7 • 2007  1436
class I loading, we compared recovery of MHC class I/peptide of 
acid-stripped DCs in the presence or absence of CHX (Fig. 8 B). 
Although translation inhibition had a strong impact on 4 h LPS-
treated DCs, fully inhibiting peptide-H-2k
b recovery, CHX had 
little effect on 16 h activated cells. The origin of the MHC class I/
presented peptides is therefore changing dramatically during 
the course of LPS stimulation. Newly activated DCs are fully 
dependent on protein synthesis to generate MHC class I restricted 
peptides in agreement with the DRiPs hypothesis, while at later 
times of maturation DCs lose this dependency. It is tempting to 
speculate that these antigens are either exogenous antigens, which 
are cross-presented or stored DRiPs, which are released by DALIS 
during their breakdown induced by the protein synthesis inhibition. 
Thus translation regulation during maturation also has an impor-
tant impact on antigen presentation by DCs.
Discussion
Our work provides an additional layer of analysis to the DC ac-
tivation process. Although transcriptional regulation is neces-
sary to acquire new functions, the regulation of gene expression 
at the level of translation provides the cell with the plasticity 
that is needed to respond to rapid changes in its environment. 
This has been shown recently in naive T helper-2 cells, which 
enter a stress response by blocking translation upon T cell re-
ceptor stimulation and retaining this state until restimulation 
(Scheu et al., 2006). Our results demonstrate that DC activation 
is divided in two distinct phases. A phase of protein synthesis 
increase during the fi  rst 4 h of DC maturation is followed by 
a phase of down-regulation involving cap-mediated translation 
inhibition. We have also provided examples of the importance 
of these two phases in DC function, illustrating how basic 
cellular processes such as regulation of mRNA translation can 
control cell differentiation and function.
Detection of LPS by TLR4 activates PI3K through the re-
cruitment of the MyD88 and TRIF adaptors, leading to AKT and 
mTOR activation and fi  nally ending by S6 protein phosphory-
lation by S6K1. This signal transduction pathway is also activated 
by growth factors in replicating cells. TLR signaling is therefore 
likely to control the cellular metabolism, in addition to its stim-
ulating role on immunity. It is a puzzling observation because 
mDCs are not dividing and therefore do not need a high rate of 
protein synthesis to sustain proliferation. Putatively, a high rate 
of translation is required for achieving the massive cellular 
changes observed upon DC maturation such as MHC and costim-
ulatory molecules up-regulation, as well as cytokine production. 
Interestingly, our observation that IL-12 secretion is prevented 
during PI3K inhibition by LY contrasts with previous results 
obtained by Fukao et al. (Fukao et al., 2002), in which DC treat-
ment with wortmannin was found to enhance IL-12 production. 
We attribute this discrepancy to the use of wortmannin, which, 
at the concentration used, is less effi  cient than LY to inhibit 
PI3K in DCs (as shown in Fig. 2 B). Partial inhibition of the 
PI3K pathway could lead to potential compensation mecha-
nisms able to promote IL-12 production.
The abrupt increase in protein synthesis is also likely to en-
hance markedly the proportion of DRiPs available for processing. 
Figure 8.  Translation regulation inﬂ  uences DC survival and MHC class I 
presentation. (A) Effect of proteasome inhibition on DC survival. Surface 
annexin V staining was quantiﬁ  ed by FACS on CD11c
+ gated cells. iDCs 
(gray bars) were sensitive to the apoptosis inducers etoposide (Etop) and 
staurosporine (Stauro), whereas mDCs (black bars) remained unaffected. 
Conversely, MG132 and Z-VAD-FMK treatment induced apoptosis in mDCs 
and had little effect in iDCs. Data are from one representative experiment 
out of four performed. (B) Origin of MHC I ligands during DC maturation. 
Surface levels of peptide-loaded K
b molecules were monitored by FACS 
using the HB-176 antibody, which recognizes conformed H-2K
b molecules 
independently of their peptide ligands. Acid stripping was used to de-
crease surface peptide loaded H-2K
b and increase the sensitivity of detect-
ing newly arriving surface MHC I molecules. Surface H-2K
b recovery over 
2 h after strip was monitored with or without chemical treatment (MG132 
or CHX) and data were plotted as a linear function where the x-value is 
time and the y-value the level of peptide-loaded MHC I. Slopes (recovery 
rate) of the linear function were compared to establish the importance of 
proteasome degradation and protein synthesis for MHC class I surface 
arrival during DC maturation (example shown in the top panel). Higher 
slopes indicate higher surface appearance of new peptide-loaded MHC I 
molecules. As expected, treatment of mDCs with the proteasome inhibitor 
MG132 decreased the MHC I recovery rate (MG, bottom left), whereas no 
difference was detected among 4 h and 16 h LPS-activated mDCs (bottom 
right). Inhibition of protein synthesis with CHX prevented the recovery of 
4 h LPS-stimulated DC but not of 16 h stimulated DC (bottom right). Error bars 
indicate the SD of ﬁ  ve independent experiments and the signiﬁ  cance was 
determined by using t test (*, P < 0.05).TRANSLATION REGULATION IN DCS • LELOUARD ET AL. 1437
In this context, DALIS probably represent an adapted stress 
  response to these radical changes in protein synthesis and to 
the massive accumulation of DRiPs in such a short time lapse. 
DALIS are dependent on the signaling pathway inducing the 
translational boost, comprising the PI3K/AKT/mTOR signaling 
axis, which is key to achieve functional DC maturation. DALIS 
formation and disappearance follow the enhancement and inhi-
bition of cap-mediated translation during DC maturation. By ac-
cumulating DRiPs, DALIS provide probably a mean to control 
the cytotoxic effects of these misfolded proteins, as well as their 
availability for degradation. Surprisingly, although the rate of 
surface arrival of peptide-loaded MHC class I does not fl  uctuate 
with maturation progression, the type of antigen presented 
changes dramatically. From fully dependent on newly synthe-
sized antigens at early time of maturation, in agreement with the 
DRiPs hypothesis, MHC class I presentation switches to a pool 
of preexisting antigens at late stages of maturation. Thus, these 
antigens could be provided by decaying DALIS or alternatively 
they could be of exogenous origin and mostly cross-presented. 
In absence of a mean to control DALIS formation effi  ciently 
without affecting DC maturation, the elucidation of their exact 
function will remain unanswered. However, we could demon-
strate that translation regulation affects the pool of antigen 
available for MHC class I presentation and that MHC class I 
  restricted presentation is radically different in cells stimulated 
with LPS for different times.
A reduction in cap-dependent translation and a shift to-
ward translation of certain IRES-containing mRNAs was observed 
after 8 h of maturation. Remarkably, this process is similar to 
the stress-induced attenuation of protein synthesis required for 
cell survival under harsh conditions. In addition to a mild phos-
phorylation of eIF2α, we observed a good correlation between 
eIF4GI and DAP5 proteolysis and the intensity of their transla-
tion during maturation. Moreover, protease inhibitors preventing 
eIF4GI and DAP5 cleavage had a strong inhibitory effect on 
the production of these molecules in a manner similar to protein 
synthesis inhibitors, thus defi  nitely linking proteolysis and trans-
lation regulation. We could show that the protease(s) responsible 
for the cleavage of eIF4GI are different from the major known 
apoptotic caspases, such as caspase-3, which is responsible for 
translation inhibition during apoptosis. Based on MG132 effects 
and on a recent report (Baugh and Pilipenko, 2004), we further 
propose that proteasome activity could be responsible, at least 
in part, for the degradation of the translation initiation factors 
and, thus, exert a control on translation in mDCs. Interestingly, 
MG132 treatment is known to affect viral IRES activity (Baugh 
and Pilipenko, 2004) as well as to induce translation reprogram-
ming of myoblasts (Cowan and Morley, 2004). The effect ob-
served with the broad range inhibitor of caspases Z-VAD-FMK 
could be due either by inhibition of an additional unidentifi  ed 
protease or by inhibition of the caspase-like activity of the 
proteasome itself because a survey of eIF4GI primary sequence 
for sites potentially targeted by the proteasome caspase-like 
activity (Kisselev et al., 2003) indicates the presence of several 
consensus sites in areas matching eIF4GI cleavage map.
Cell death appears to be a normal response to counter-
balance the activation of the proliferation machinery (including pro-
tein synthesis enhancement). The establishment of anti-apoptotic 
conditions during DC maturation seems dependent, at least in 
part, on the switch in the quality of translation induced by pro-
teolytic cleavage of eIF4GI and DAP5. LPS detection by DCs 
is therefore integrated in a binary response containing a growth 
factor-like and a stress-like phase. This response is adapted to the 
need for rapid changes in the physiology of DCs after pathogen 
detection. Marked up-regulation of protein synthesis probably 
favors apoptosis through the accumulation of misfolded proteins. 
DCs therefore take advantage of the second phase to enhance 
their survival rate and augment their capacity to interact with 
other cells during their migration. Whether this phase is directly 
triggered by LPS or indirectly by an autocrine cytokine loop 
 remains to be evaluated. IL-6 could cause some of these changes 
because it has been shown to favor some IRES-mediated trans-
lation (Yamagiwa et al., 2004).
Materials and methods
Cell culture
Male C57BL/6 mice 7–8 wk old were purchased from Charles River Labo-
ratories. MyD88 and TRIF
−/− mice were obtained from L. Alexopoulou 
(CIML, Marseille, France). Bone marrow–derived DCs were cultured as de-
scribed previously (Lelouard et al., 2004). Maturation was induced using 
100 ng/ml LPS or 20 μg/ml poly I:C.
Chemicals
All chemicals were purchased from Sigma-Aldrich, except Z-VAD-FMK, 
Z-DEVD-FMK, Ac-YVAD-CMK, and Ac-LEHD-FMK (from Bachem); Z-IETD-
FMK, Z-WEHD-FMK, rapamycin, and LY294002 (from Calbiochem); and 
MG132 (from BIOMOL International, L.P.). iDCs were treated with 100 μM 
LY294002 or 1 mM rapamycin for 1 h before LPS treatment. Wortmannin 
was used at 1 μM for 30 min before activation. 0.5 mM sodium arsenite 
was added for 30 min to iDCs or to 16 h LPS-treated DCs. 10–80 μM 
Z-VAD-FMK; 0.5–2 μM MG132; 2 μM LHVS (gift of H. Ploegh, Massachusetts 
Institute of Technology, Cambridge, MA); 100 μM Z-DEVD-FMK, Ac-YVAD-
CMK, Ac-LEHD-FMK; 40 μM Z-IETD-FMK, Z-WEHD-FMK; 25 μM CHX; 
50 μM etoposide; or 0.2–1 μM staurosporin was added for 10 h to iDC or 
to 6 h LPS-treated DC.
Immunoblotting
50 μg of Triton X-100–soluble material was loaded on 2–12% gradient 
SDS-PAGE before immunoblotting and chemiluminescence detection (Pierce 
Chemical Co.). Polyclonal antibodies against eIF4A, Nt eIF4GI, and Nt 
DAP5 were from Santa Cruz Biotechnology, Inc.; polyclonal antibodies 
against phospho-S6, phospho-S6K1, S6, phospho-AKT, eIF2α, and Ct 
DAP5 were from Cell Signaling Technology; polyclonal antibody against 
phospho-eIF2α was from Invitrogen. Polyclonal antibodies speciﬁ  c for 
eIF4GI peptides P7, P8, and P9 were a gift of R. Rhoads (Louisiana State 
University, Baton Rouge, LA). Others polyclonal antibodies speciﬁ  c for eIF4GI 
and eIF4GII were gifts of S.J. Morley (University of Sussex, Brighton, UK). 
Secondary antibodies were from Jackson ImmunoResearch Laboratories and 
from Invitrogen. Immunoﬂ  uorescence and confocal microscopy was performed 
with a microscope (LSM 510; Carl Zeiss, Inc.) using a 63× objective and 
accompanying imaging software.
MHC class I surface recovery by acid striping assay
5 × 10
6 cells were washed in PBS/0.1%BSA and resuspended in 0.5 ml 
of 0.2 M citric acid/0.2 M Na2HPO4 buffer (pH 3.0) and incubated on ice 
for 2 min. The cell suspension was neutralized by adding excess of ice-cold 
PBS/BSA and after centrifugation cells were immediately stained for FACS 
analysis or for recovering resuspended in LPS-free medium with or without 
drugs. Cell surface K
b molecules were measured by FACS after staining 
with HB176 (gift of Günter Hämmerling and Franck Momburg, Heidelberg).
m
7G-cap binding assay
500 μg of soluble fraction were diluted in 300 μl lysis buffer and incu-
bated with 20 μl packed 7-Methyl GTP-Sepharose 4B (GE Healthcare) for 
2 h at 4°C. After washing with lysis buffer, the beads were applied to SDS-
PAGE and immunoblot was performed as above.JCB • VOLUME 179 • NUMBER 7 • 2007  1438
Plasmids and in vitro transcription
Constructs are in a pBluescript-KS (Stratagene) vector. Plasmids encoding 
ﬁ  reﬂ  y luciferase, pT3LUC(pA), was the gift of M. Hentze (EMBL, Heidelberg). 
20 μg plasmid DNA were linearized and puriﬁ  ed with the QIAquick PCR 
puriﬁ  cation KIT (QIAGEN). 10 μl linearized DNA were in vitro transcribed 
in the presence of either 
7mGpppG or ApppG (Ambion) using the Ribo-
probe in vitro Transcription System-T3 (Promega). In vitro transcribed 
mRNA was puriﬁ  ed using the RNeasy Mini kit (QIAGEN).
mRNA transfection
iDCs were transfected on d 5 of culture. Before transfection, iDCs were 
washed twice with ice-cold PBS. DCs were then adjusted to a ﬁ  nal cell den-
sity of 20 × 10
6 cells/ml. 200 μl of the cell suspension (4 × 10
6 cells) was 
preincubated in a 4-mm gap electroporation cuvette (Bio-Rad Laboratories) 
for 5 min on ice. In vitro–transcribed mRNA (5 μg) was added to the cell 
suspension and cells were pulsed with a Gene Pulser II apparatus (Bio-Rad 
Laboratories), using a voltage of 500 V, a capacitance of 50 μF, and pulse 
times ranging from 2 to 4 ms. After electroporation, cells were immediately 
resuspended in fresh prewarmed culture medium. After 4 h, cells were har-
vested and luciferase activity was determined with a Luciferase Reporter 
Assay System (Promega) in a Wallace 1420 multilabel counter VICTOR
2.
Online supplemental material
Figures presenting the effect of MyD88 and TRIF deﬁ   ciency on DC 
maturation, the cap-binding activity of eIF4GI fragments and DAP5 isoforms
expression in DCs are displayed as supplementary ﬁ  gures.Online sup-
plemental material is available at http://www.jcb.org/cgi/content/full/
jcb.200707166/DC1.
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